Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Subjects

Clinical trial NCT00125346 · TERMINATED

Trial details

NCT number: NCT00125346
Sponsor: Novartis
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2005-09-01
Primary completion: 2007-02-01
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.